179 related articles for article (PubMed ID: 8841439)
21. Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.
Aslam A; Newman TL; Misbah SA
J Clin Pathol; 2003 Oct; 56(10):775-7. PubMed ID: 14514783
[TBL] [Abstract][Full Text] [Related]
22. Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate.
Pollock W; Clarke K; Gallagher K; Hall J; Luckhurst E; McEvoy R; Melny J; Neil J; Nikoloutsopoulos A; Thompson T; Trevisin M; Savige J
J Clin Pathol; 2002 Sep; 55(9):680-3. PubMed ID: 12194998
[TBL] [Abstract][Full Text] [Related]
23. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.
Ruffatti A; Sinico RA; Radice A; Ossi E; Cozzi F; Tonello M; Grypiotis P; Todesco S
J Rheumatol; 2002 May; 29(5):918-23. PubMed ID: 12022350
[TBL] [Abstract][Full Text] [Related]
25. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
26. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
Sun J; Fass DN; Hudson JA; Viss MA; Wieslander J; Homburger HA; Specks U
J Immunol Methods; 1998 Feb; 211(1-2):111-23. PubMed ID: 9617836
[TBL] [Abstract][Full Text] [Related]
27. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
Holland M; Hewins P; Goodall M; Adu D; Jefferis R; Savage CO
Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic ANCA algorithms in daily clinical practice: evidence, experience, and effectiveness.
Avery TY; Bons J; van Paassen P; Damoiseaux J
Lupus; 2016 Jul; 25(8):917-24. PubMed ID: 27252270
[TBL] [Abstract][Full Text] [Related]
29. Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
Phatak S; Aggarwal A; Agarwal V; Lawrence A; Misra R
Int J Rheum Dis; 2017 Jun; 20(6):774-778. PubMed ID: 27457216
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
Sowa M; Grossmann K; Knütter I; Hiemann R; Röber N; Anderer U; Csernok E; Bogdanos DP; Borghi MO; Meroni PL; Schierack P; Reinhold D; Conrad K; Roggenbuck D
PLoS One; 2014; 9(9):e107743. PubMed ID: 25225805
[TBL] [Abstract][Full Text] [Related]
32. Development and standardization of solid-phase assays for the detection of antineutrophil cytoplasmic antibodies (ANCA) for clinical application: report of a large clinical evaluation study.
Hagen EC
Clin Exp Immunol; 1995 Jul; 101 Suppl 1(Suppl 1):29. PubMed ID: 7606857
[No Abstract] [Full Text] [Related]
33. Antigen-Specific Detection of Autoantibodies Against Myeloperoxidase (MPO) and Proteinase 3 (PR3).
Vanderlocht J; van Beers JJBC; Limburg PC; Damoiseaux J; Roozendaal C
Methods Mol Biol; 2019; 1901():153-176. PubMed ID: 30539575
[TBL] [Abstract][Full Text] [Related]
34. How are antineutrophil cytoplasmic autoantibodies detected?
Wieslander J
Am J Kidney Dis; 1991 Aug; 18(2):154-8. PubMed ID: 1867172
[TBL] [Abstract][Full Text] [Related]
35. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
[TBL] [Abstract][Full Text] [Related]
36. Antineutrophil cytoplasmic antibodies (ANCAs) in patients with inflammatory bowel disease show no correlation with proteinase 3, lactoferrin, myeloperoxidase, elastase, cathepsin G and lysozyme: a Singapore study.
Ooi CJ; Lim BL; Cheong WK; Ling AE; Ng HS
Ann Acad Med Singap; 2000 Nov; 29(6):704-7. PubMed ID: 11269973
[TBL] [Abstract][Full Text] [Related]
37. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
[TBL] [Abstract][Full Text] [Related]
38. A simple high yield procedure for purification of human proteinase 3, the main molecular target of cANCA.
Stummann L; Wiik A
J Immunol Methods; 1997 Aug; 206(1-2):35-42. PubMed ID: 9328566
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD).
Trevisin M; Pollock W; Dimech W; Savige J
J Immunol Methods; 2008 Jul; 336(2):104-12. PubMed ID: 18499121
[TBL] [Abstract][Full Text] [Related]
40. An international survey on anti-neutrophil cytoplasmic antibodies (ANCA) testing in daily clinical practice.
Damoiseaux J; Heijnen I; Van Campenhout C; Eriksson C; Fabien N; Herold M; van der Molen RG; Egner W; Patel D; Plaza-Lopez A; Radice A; de Sousa MJR; Viander M; Shoenfeld Y
Clin Chem Lab Med; 2018 Sep; 56(10):1759-1770. PubMed ID: 28710880
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
